2.30
7.63%
-0.19
Dopo l'orario di chiusura:
2.30
Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie
BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit - Yahoo Finance
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 0.9%Here's Why - MarketBeat
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting - ACCESS Newswire
With BioRestorative Therapies Up 18%, Insider Buyers Count Their Returns - Simply Wall St
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Up 0.7%Here's Why - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Up 0.7% – Here’s What Happened - Defense World
BioRestorative Therapies, Inc. announced that it has received $1 million in funding - Marketscreener.com
Pleasing Signs As A Number Of Insiders Buy BioRestorative Therapies Stock - Yahoo Finance
BioRestorative Therapies (OTCMKTS:BRTX) Share Price Passes Above Fifty Day Moving Average – Here’s What Happened - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 12-Month HighTime to Buy? - MarketBeat
BioRestorative Therapies Announces Notice of Allowance of - GlobeNewswire
BioRestorative Therapies Secures Key European Patent for Revolutionary Obesity Treatment Technology - StockTitan
BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial - Nasdaq
BioRestorative Ends Q3 In 'Strong' Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain TrialEli Lilly (NYSE:LLY), BioRestorative Therapies (NASDAQ:BRTX) - Benzinga
Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market - Nasdaq
BioRestorative Therapies Provides Business Update and Financial Results for Q3 2024 - Defense World
Analyzing American Caresource (OTCMKTS:GNOW) & BioRestorative Therapies (NASDAQ:BRTX) - Defense World
BioRestorative Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q3 2024 Earnings Call Transcript - Insider Monkey
BioRestorative Therapies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
BioRestorative Therapies earnings beat by $0.31, revenue fell short of estimates - Investing.com Canada
BioRestorative Therapies Q3 2024 Financial Update - TipRanks
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function - Benzinga
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data - OrthoSpineNews
BioRestorative's BRTX-100 Shows 100% Success Rate in Early Back Pain Trial Data | BRTX Stock News - StockTitan
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
BioRestorative Therapies Enters at-the-Market Offering Agreement with Rodman & Renshaw LLC - Defense World
Roth Capital Issues Optimistic Outlook for BRTX Earnings - Defense World
BioRestorative Therapies to Announce Phase 2 Trial Data - TipRanks
Research Analysts Offer Predictions for BRTX Q1 Earnings - Defense World
BioRestorative Therapies inks new equity deal - Investing.com
BioRestorative Therapies inks new equity deal By Investing.com - Investing.com UK
BRTXBioRestorative Therapies, Inc. Latest Stock News & Market Updates - StockTitan
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium - The Manila Times
BioRestorative to Present Expanded BRTX-100 Phase 2 Trial Data for Chronic Back Pain Treatment | BRTX Stock News - StockTitan
Broadrick Dale reduces stake in BioRestorative Therapies, Inc. with $1,756 sale - Investing.com
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Reaches New 12-Month HighShould You Buy? - MarketBeat
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 1-Year HighHere's Why - MarketBeat
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 52-Week HighWhat's Next? - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 1-Year High at $1.79 - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):